Clinical Trial

Diagnosis, Prognosis, and Mechanisms in Panvascular Disease

Study acronym: PRO-PVD
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to establish a standardized cohort for panvascular diseases, encompassing biological materials such as DNA samples, along with extensive patient medical records and follow-up information. The design of this database will enable it to serve as a comprehensive resource for future medical research. Upon data collection, researchers will conduct various statistical analyses to enhance our understanding of the factors and mechanisms contributing to various panvascular diseases, including coronary heart disease, myocardial infarction, stroke, and peripheral vascular disease. These statistical analyses will also aid in identifying more effective treatment strategies for these conditions. By amassing a large volume of data from a significant number of patients with panvascular diseases, researchers will be able to perform highly precise analyses of the factors influencing the onset, progression, and treatment of these diseases. The results of these precise analyses can then be utilized to optimize clinical practices for the prevention and treatment of panvascular diseases.
Trial Details
NCT Number NCT07151183
Lead Sponsor Jinwei Tian
Conditions Panvascular Diseases, Cardiovascular Diseases
Enrollment 1,000 participants
Start Date 2024-12-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-03